Sentrex Health Solutions Inc. acquires PerCuro Clinical Research Ltd., enhancing its specialty healthcare services in Canada. PerCuro’s nurse-led model expands healthcare access for various conditions, aligning with Sentrex’s patient-centric approach. Founder Leeanna Bulinckx anticipates broader service reach, reflecting on shared care values. Dr. Kevin Rioux praises PerCuro’s care quality and foresees amplified benefits post-integration. Sentrex CEO Taflyn Hornibrook expresses excitement for the collaboration, emphasizing a commitment to innovation and patient outcomes. Both entities prioritize seamless care continuity throughout the transition.
Sentrex Health Solutions Inc., a leading provider of specialty healthcare services in Canada, is excited to announce the acquisition of PerCuro Clinical Research Ltd.—one of Canada’s premier providers of infusion services, clinical research, and advanced nursing care. This acquisition marks a significant step in Sentrex’s mission of bringing innovative healthcare offerings to more patients across the country.
Renowned for its nurse-led model of care, PerCuro (Latin for “to heal thoroughly”) fulfills a significant need in helping to deliver crucial medical services to patients across several therapeutic areas, including inflammatory bowel disease, liver disease, neurology, dermatology, and rare diseases. Established in 2003, PerCuro has become an essential partner among healthcare providers on Vancouver Island and is able to bring healthcare services closer to physicians and patients.
Commenting on the acquisition, Leeanna Bulinckx, Founder & CEO of PerCuro, said: “Joining forces with Sentrex represents a pivotal moment for us. We’re excited to extend our tried-and-true PerCuro model beyond Vancouver Island to serve patients, and Sentrex, with its similar focus on exceptional patient care, will make this possible.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Dr. Kevin Rioux, Gastroenterologist and Medical Lead for GI Central Access and Triage, is a respected physician who has collaborated extensively with PerCuro and shared their insights on the acquisition: “My experience working with PerCuro’s team has always been exemplary. Their nurse-led model not only enhances the quality of care for patients but also bridges the gap between specialist care and patient accessibility. The integration of PerCuro into Sentrex promises to extend these benefits on a greater scale. I look forward to seeing how this enhanced collaboration will further improve the patient experience.
Additionally, Taflyn Hornibrook, CEO of Sentrex, said: “We are thrilled that the amazing team from PerCuro is joining Sentrex. When looking to expand our infusion and nursing services, it was important to us that we find a team who shares our commitment to delivering the highest standard of patient care, as well as leaders who share our passion for delivering exceptional outcomes for patients and our partners. Acquiring PerCuro is a milestone in Sentrex’s ongoing mission to be Canada’s most innovative and patient-focused provider of specialty health solutions”.
Both organizations are dedicated to delivering seamless care through this transition, while ensuring continued high-quality care for all patients and stakeholders involved.
Source: Bio Space